NA
Nanobiotix
NBTX
NYSE EURONEXT - EURONEXT PARISHealth Care
Income Statement
Total Revenue$113.2M
Gross Profit$113.2M
Operating Income$-160.51M
EBITDA$-138.92M
EBIT$-145.66M
Pre-tax Income$-84.41M
Net Income$-203.3M
Balance Sheet
Net Cash$46.93M
Cash Equivalent$69.53M
Total Debt$53.74M
Net Debt$6.81M
Book Value$-18.53M
Net Cash Per Share0.97
Book Value Per Share-0.42
Key Ratios
Return on Equity (ROE)-175.45%
Return on Assets (ROA)-101.06%
Return on Invested Capital (ROI)-67.39%
Net Profit Margin-132.08%
Current Ratio1.04
Quick Ratio0.99
Long-Term Debt / Equity1.13